Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Oct 13, 2021
Evaluation of the Relaxation State of Amorphous Itraconazole Using Solution Calorimetry
Read more
Scientific Article
/ Oct 18, 2021
Spray-Dried Composite Formulation Containing DSPC for Lung Sustained Release
Read more
Scientific Article
/ Oct 17, 2021
Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures
Read more
Scientific Article